Evidence map›Paper›PMID 37679387›Full record

ArticleNature communications2023

Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif.

A Brkic, M Leibundgut, J Jablonska, V Zanki, Z Car, V Petrovic Perokovic, A Marsavelski, N Ban, I Gruic-Sovulj

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 4 countries.

A BrkicDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000, Zagreb, Croatia.
M LeibundgutDepartment of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093, Zürich, Switzerland.
J JablonskaDepartment of Biomolecular Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel.
V ZankiDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000, Zagreb, Croatia.ORCID http://orcid.org/0000-0001-9934-0571
Z CarDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000, Zagreb, Croatia.ORCID http://orcid.org/0000-0002-7301-6615
V Petrovic PerokovicDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000, Zagreb, Croatia.
A MarsavelskiDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000, Zagreb, Croatia.ORCID http://orcid.org/0000-0003-1139-7173
N BanDepartment of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093, Zürich, Switzerland. ban@mol.biol.ethz.ch.ORCID http://orcid.org/0000-0002-9527-210X
I Gruic-SovuljDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000, Zagreb, Croatia. gruic@chem.pmf.hr.ORCID http://orcid.org/0000-0002-3930-8323
University of Zagreb · HRETH Zurich · CHWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics target key biological processes that include protein synthesis. Bacteria respond by developing resistance, which increases rapidly due to antibiotics overuse. Mupirocin, a clinically used natural antibiotic, inhibits isoleucyl-tRNA synthetase (IleRS), an enzyme that links isoleucine to its tRNA

Indexed as

Amino Acyl-tRNA SynthetasesMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsCatalytic DomainDrug Resistance, MicrobialIsoleucineMupirocinAmino Acyl-tRNA SynthetasesAnti-Bacterial AgentsIsoleucineMupirocin

Identifiers

PMID37679387
PMCPMC10485003
OpenAlexW4386507605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.